Related references
Note: Only part of the references are listed.Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Ariane K. Kawata et al.
HEADACHE (2021)
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Stewart J. Tepper et al.
CEPHALALGIA (2020)
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Burden of Illness Among People with Migraine and >= 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine
Dawn C. Buse et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2020)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States
J. Michael Woolley et al.
HEADACHE (2017)
A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine
Amaal J. Starling et al.
CURRENT PAIN AND HEADACHE REPORTS (2015)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
Systematic Review of Migraine Prophylaxis Adherence and Persistence
Zsolt Hepp et al.
JOURNAL OF MANAGED CARE PHARMACY (2014)
Review: Approved and some off-label preventive drugs reduce migraine frequency in episodic migraine
Alexander W. Chessman
ANNALS OF INTERNAL MEDICINE (2013)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review
Michel Lanteri-Minet et al.
CEPHALALGIA (2011)
The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis
Elisabeth Hazard et al.
VALUE IN HEALTH (2009)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Share Paper
